Tacrolimus
Specifications
- Brand
- YC
- Origin
- Hubei China
- Certifications
- ISO9001
- MOQ
- 5Kg
- Packaging
- As your request
- Price Term
- FOB CIF
- Payment Term
- T/T,WesternUnion,Moneygram
- Supply Ability
- 4500Kg/Month
- Delivery Time
- 4-6 working days
- Loading Ports
- Shenzhen Hongkong Shanghai
- Guarantee
- ISO9001
Tacrolimus is a Chemicals product. Key specs — Brand: YC; Origin: Hubei China; Certifications: ISO9001; MOQ: 5Kg.
Product Description
Product Name: Tacrolimus Synonyms: (2-propenyl)-,(3s-(3r*(e(1s*,3s*,4s*)),4s*,5r*,8s*,9e,12r*,14r*,15s*,16r*,18s*;,19s*,26ar*))-;16-dimethoxy-4,10,12,18-tetramethyl-8-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1;19-epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4h,23h)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-14,16-dim;6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-5;fr900506;prograf;tsukubaenolide CAS: 104987-11-3 MF: C44H69NO12 MW: 804.02 Product Categories: Active Pharmaceutical Ingredients;Immunosuppressant.;Intermediates & Fine Chemicals;Pharmaceuticals;API;Chiral Reagents;Fujimycin, Prograf;antibiotic mp 113-115°C storage temp. ?20°C solubility DMSO: >3 mg/mL form solid color white Chemical Properties White Crystalline Solid Usage An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2.
Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release.
Usage FK-506 (Tacrolimus) is a macrolide immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system Usage Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants.
Tacrolimus acts by blocking T cell proliferation in vitro by inhibiting the generation of several lymphokines, notably the original target IL-2. Tacrolimus inhibits the activity of FK-506 binding protein, Ca2+-dependent phosphatase and calcineurin, and activates NF-κB through phosphorylation and degradation of IκBα.
Usage treatment of Cushing's syndrome Usage For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart.
Related Products
1-Isobutyl-2-MethyliMidazole 116680-33-2
1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-methanol
Climbazole 38083-17-9
4-Methyl-2-phenylimidazole 827-43-0
1-Benzyl-2-methylimidazole 13750-62-4
Oxymetholone 434-07-1 Anabolic Steroid Powder Anadrol Powder Pharmaceutical Material
Primobolan 434-05-9 Nandrolone Powder Pituitary Growth Hormone Methenolone Acetate
Methenolone Enanthate Primobolan Enanthate Raw Steroid Nandrolone Powder 303-42-4